Claudi Bockting
Prof. Clinical Psychology in Psychiatry Amsterdam UMC / Clinical Psychologist
Profile
Claudi L. Bockting, PhD, is Professor of Clinical Psychology in the Department of Psychiatry at Amsterdam University Medical Center, The Netherlands, and cofounder and codirector of the interdisciplinary Centre for Urban Mental Health at the University of Amsterdam. Her research focuses on finding potentially modifiable factors that can be targeted with innovative interventions to prevent or treat depression, anxiety, and suicidality.
She is the developer of preventive cognitive therapy (PCT) as a treatment against relapse in depressive disorders. Dr. Bockting has been a practicing clinical psychologist since 1993 and is author or coauthor of more than 200 peer-reviewed publications in leading journals such as Nature, World Psychiatry, JAMA Psychiatry, and Lancet Psychiatry, and wrote several intervention books. She offers international intervention workshops focused on treatment of depression and anxiety as well as relapse prevention.
Dr. Bockting was a visiting professor in the Department of Global Health and Social Medicine at Harvard Medical School in 2023. She is the recipient of an honorary doctorate from the University of Basel, an elected membership in the European Academy of Sciences and Arts, and fellowships at the Beck Institute, the Institute for Advanced Study at the University of Amsterdam, and the World Health Organization. Her website is Intervention Lab | Claudi Bockting.
Talk Topic
In her talk, “Disrupt the rhythm of depression,” Claudi explores how depression is not only a condition of individual suffering but also shaped by social and interpersonal factors. Research shows that people who recover from an episode of depression frequently experience relapse; this talk addresses the mechanisms that explain this high risk of relapse and which interventions can disrupt that recurring rhythm.
She will outline psychological interventions (including Preventive Cognitive Therapy; PCT) designed to meet the needs of individuals in partial remission or those fully remitted, targeting risk factors for relapse such as stress sensitivity, dysfunctional cognitive patterns, and emotion regulation. The talk will include evidence for long-term preventive effects up to 20 years.
